# Safety and Efficacy of Lorbrena

> **NCT03844464** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 1290 (actual)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03844464
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-21
- **Primary completion:** 2025-07-30
- **Final completion:** 2025-07-30
- **Target enrollment:** 1290 (ACTUAL)
- **Last updated:** 2025-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03844464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03844464, "Safety and Efficacy of Lorbrena". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03844464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*